Gilead encountered a significant setback concerning its antibody-drug conjugate ...
Sanofi, the prominent pharmaceutical conglomerate, has undertaken a recent merge...
Surrozen finds itself at a crossroads in its pursuit of a treatment for inflamma...
AM-Pharma B.V. announced that the first individuals have been given treatment in...
Sun Pharmaceutical and Taro Pharmaceutical have formally announced their merger ...
Balversa (erdafitinib) has received complete approval from the FDA, permitting i...
The Swiss Contract Development and Manufacturing Organization (CDMO) is now sign...
Disco Pharmaceuticals has recently taken the pharmaceutical stage, bolstered by ...
BioNTech, the renowned German biotechnology powerhouse, has engaged in a substan...
Alcon’s recent acquisition of Aerie Pharmaceuticals for $770 million is proving ...
China has officially granted approval for the sale of Leqembi, a revolutionary A...
Researchers from Harvard University and the Broad Institute, led by Dr. David Li...
GSK has revealed a contract to acquire Aiolos Bio and its phase 2 asthma medicin...
In a strategic accord forged in tandem with Flagship Pioneering, Novo Nordisk ha...
In response to the occurrence of two fatalities within its VX-880 diabetes drug ...
With the agreement to shell out $680 million for Harpoon Therapeutics and its on...
